Literature DB >> 28941115

Moving interventions from after to before diagnosis.

Iris E Sommer1, Celso Arango2.   

Abstract

Year:  2017        PMID： 28941115      PMCID： PMC5608816          DOI： 10.1002/wps.20454

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  9 in total

1.  Neurocognitive performance and functional disability in the psychosis prodrome.

Authors:  Tara A Niendam; Carrie E Bearden; Jennifer K Johnson; Malin McKinley; Rachel Loewy; Mary O'Brien; Keith H Nuechterlein; Michael F Green; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2006-03-24       Impact factor: 4.939

2.  Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort.

Authors:  Mary Cannon; Avshalom Caspi; Terrie E Moffitt; HonaLee Harrington; Alan Taylor; Robin M Murray; Richie Poulton
Journal:  Arch Gen Psychiatry       Date:  2002-05

3.  Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study.

Authors:  R Poulton; A Caspi; T E Moffitt; M Cannon; R Murray; H Harrington
Journal:  Arch Gen Psychiatry       Date:  2000-11

4.  Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.

Authors:  Eva Velthorst; Dorien H Nieman; Hiske E Becker; Reinaud van de Fliert; Peter M Dingemans; Rianne Klaassen; Lieuwe de Haan; Thérèse van Amelsvoort; Don H Linszen
Journal:  Schizophr Res       Date:  2009-03-09       Impact factor: 4.939

5.  Four-Year Follow-up of Cognitive Behavioral Therapy in Persons at Ultra-High Risk for Developing Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.

Authors:  Helga K Ising; Tamar C Kraan; Judith Rietdijk; Sara Dragt; Rianne M C Klaassen; Nynke Boonstra; Dorien H Nieman; Monique Willebrands-Mendrik; David P G van den Berg; Don H Linszen; Lex Wunderink; Wim Veling; Filip Smit; Mark van der Gaag
Journal:  Schizophr Bull       Date:  2016-03-18       Impact factor: 9.306

6.  A Swedish National Prospective and Co-relative Study of School Achievement at Age 16, and Risk for Schizophrenia, Other Nonaffective Psychosis, and Bipolar Illness.

Authors:  Kenneth S Kendler; Henrik Ohlsson; Briana Mezuk; Kristina Sundquist; Jan Sundquist
Journal:  Schizophr Bull       Date:  2015-07-31       Impact factor: 9.306

7.  Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.

Authors:  Patrick D McGorry; Barnaby Nelson; Connie Markulev; Hok Pan Yuen; Miriam R Schäfer; Nilufar Mossaheb; Monika Schlögelhofer; Stephan Smesny; Ian B Hickie; Gregor Emanuel Berger; Eric Y H Chen; Lieuwe de Haan; Dorien H Nieman; Merete Nordentoft; Anita Riecher-Rössler; Swapna Verma; Andrew Thompson; Alison Ruth Yung; G Paul Amminger
Journal:  JAMA Psychiatry       Date:  2017-01-01       Impact factor: 21.596

8.  Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study.

Authors:  Madeline H Meier; Avshalom Caspi; Abraham Reichenberg; Richard S E Keefe; Helen L Fisher; HonaLee Harrington; Renate Houts; Richie Poulton; Terrie E Moffitt
Journal:  Am J Psychiatry       Date:  2014-01       Impact factor: 18.112

9.  Specificity of childhood psychotic symptoms for predicting schizophrenia by 38 years of age: a birth cohort study.

Authors:  H L Fisher; A Caspi; R Poulton; M H Meier; R Houts; H Harrington; L Arseneault; T E Moffitt
Journal:  Psychol Med       Date:  2013-01-10       Impact factor: 7.723
  9 in total
  2 in total

1.  Preventive psychiatry: a blueprint for improving the mental health of young people.

Authors:  Paolo Fusar-Poli; Christoph U Correll; Celso Arango; Michael Berk; Vikram Patel; John P A Ioannidis
Journal:  World Psychiatry       Date:  2021-06       Impact factor: 79.683

2.  The effects of mango leaf extract during adolescence and adulthood in a rat model of schizophrenia.

Authors:  Jose Antonio Garcia-Partida; Sonia Torres-Sanchez; Karina MacDowell; Maria Teresa Fernández-Ponce; Lourdes Casas; Casimiro Mantell; María Luisa Soto-Montenegro; Diego Romero-Miguel; Nicolás Lamanna-Rama; Juan Carlos Leza; Manuel Desco; Esther Berrocoso
Journal:  Front Pharmacol       Date:  2022-07-26       Impact factor: 5.988
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.